FindTrial
Sign In

We are comparing the decease in pain sensation after giving Femoral nerve block and Nalbuphine intravenously in patients with intertrochanteric fractures

Comparative study of effectiveness of femoral nerve block versus Intravenous Nalbuphine in positioning of patients of Intertrochanteric fractures for Spinal anaesthesia.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/10/021579
Enrollment
70
Registered
2019-10-09
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M84- Disorder of continuity of bone

Interventions

Intervention1: GROUP A: Patients will receive Femoral nerve block with single injection of 20 ml 0.2% Ropivacaine 15 minutes prior to positioning of patients for spinal anaesthesia Control Interventio

Sponsors

DrPragna Doppalapudi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: -Age group 18-80 years;of either sex -ASA I,II scheduled for intertrochanteric fracture surgeries under spinal anaesthesia. -patients who give a valid informed consent

Exclusion criteria

Exclusion criteria: -Any contra-indication for spinal anaesthesia, femoral nerve block or use of opioids/ local anaesthetics -patients with polytrauma,infection over injection site -patients who refuse for participation in study

Design outcomes

Primary

MeasureTime frame
To compare the effect of femoral nerve block vs intravenous Nalbuphine for the ease of patient positioning and relief of pain in patients of intertrochanteric fractures undergoing spinal anaesthesia.Timepoint: 0,2,5,10,15,20 minutes,during positioning—

Secondary

MeasureTime frame
To assess the time taken to perform spinal anaesthesia between both groups of patients. To assess patients acceptance.Timepoint: 0,2,5,10,15,20minutes,during positioning—

Countries

India

Contacts

Public ContactDr Pragna Doppalapudi

Kalinga Institute of Mediacal Sciences

dpragna591@gmail.com7989062115

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026